Nanologica AB (publ) (STO:NICA)
0.5760
+0.0080 (1.41%)
Jun 11, 2026, 5:24 PM CET
Nanologica AB Employees
Nanologica AB had 72 employees as of March 31, 2026. The number of employees increased by 56 or 350.00% compared to the same quarter last year.
Employees
72
Change
56
Growth
350.00%
Revenue / Employee
442.11K SEK
Profits / Employee
334.28K SEK
Market Cap
189.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 72 | 56 | 350.00% |
| Dec 31, 2025 | 19 | 3 | 18.75% |
| Sep 30, 2025 | 19 | 3 | 18.75% |
| Jun 30, 2025 | 18 | 2 | 12.50% |
| Mar 31, 2025 | 16 | 0 | - |
| Dec 31, 2024 | 16 | 0 | - |
| Sep 30, 2024 | 16 | 2 | 14.29% |
| Jun 30, 2024 | 16 | -3 | -15.79% |
| Mar 31, 2024 | 16 | -4 | -20.00% |
| Dec 31, 2023 | 16 | -4 | -20.00% |
| Sep 30, 2023 | 14 | -6 | -30.00% |
| Jun 30, 2023 | 19 | 2 | 11.76% |
| Mar 31, 2023 | 20 | 2 | 11.11% |
| Dec 31, 2022 | 20 | 3 | 17.65% |
| Sep 30, 2022 | 20 | 0 | - |
| Jun 30, 2022 | 17 | -3 | -15.00% |
| Mar 31, 2022 | 18 | -2 | -10.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Diamyd Medical AB | 41 |
| Xbrane Biopharma AB | 28 |
| NextCell Pharma AB | 24 |
| Xintela AB | 11 |
| Alligator Bioscience AB | 11 |
| AlzeCure Pharma AB | 10 |
| Isofol Medical AB | 6 |
| Active Biotech AB | 5 |
Nanologica AB News
- 22 days ago - Nanologica AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Nanologica AB Quarterly report: Q4 2025 - Filings
- 3 months ago - Nanologica AB Annual report: Q4 2025 - Filings
- 8 months ago - Nanologica AB Quarterly report: Q3 2025 - Filings
- 1 year ago - Nanologica AB Quarterly report: Q2 2025 - Filings